This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Risk parity assigns capital to balance risk contributions across asset classes in retirement portfolios, aiming for steadier, more resilient returns.
26,821 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
June brought a dramatic shift in Bitcoin ETF flows, but that doesn’t spell doom for the crypto thesis. This guide exp...
A sharp, near-$99 million exit from this cybersecurity stock has analysts buzzing about a possible shift in investor ...
Nu Holdings signals growing resilience as it posts a record Q1. This deep dive explains what the results mean for NU ...
NVIDIA stock has fallen over the past month, triggering worries about headlines and momentum. This article breaks dow...
A bold investment in a brain health biotech signals conviction in early-stage science. This article breaks down what ...
The EMB ETF offers a ~6% yield on USD EM debt, but a hidden sovereign default risk can erode income and NAV during ma...
Both Microsoft and Palantir just hit 52-week lows, but the right move isn’t the same for every investor. This guide b...
When a high profile government move hits a new domain in the headlines, markets pay attention. This piece breaks down...
Bitcoin slipped below $73,000 as ETF outflows intensified and risk-off trading took hold amid escalating geopolitical...
In 2026, investors face a choice between a specialized look at nuclear power and the broader oil and gas market. This...
Midweek headlines can turn crypto markets on a dime. This piece explains the drivers behind bitcoin sinking wednesday...